880138P
DSPE-PEG(2000) Carboxy NHS
Manufacturer: Sigma Aldrich
CAS Number: 2410279-87-5
Synonym(S): DSPE-PEG(2000) Carboxy NHS, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000, NHS ester] (sodium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 880138P-25-MG | In Stock | ₹ 44,999.53 |
880138P - 25 MG
In Stock
Quantity
1
Base Price: ₹ 44,999.53
GST (18%): ₹ 8,099.915
Total Price: ₹ 53,099.445
Assay
>99% (TLC)
form
powder
packaging
package of 1 × 10 mg
manufacturer/tradename
Avanti Polar Lipids
application(s)
advanced drug delivery
lipid type
polymerizable lipids
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 2410279-87-5 | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000, NHS ester] (sodium salt) | A2B Chem | ₹ 1,22,350.80 |
Related Products
Description
- Application: Enhanced detection of myeloma cells: DSPE-PEG(2000) Carboxy was used to create fluorescence labeled XT5 modified nano-capsules, enhancing the sensitivity of detecting myeloma cells. This application demonstrates its potential in biomedical diagnostics and targeted therapy (Norouz Dizaji et al., 2022).Improving drug encapsulation efficiency: The use of DSPE-PEG(2000) Carboxy in pre-formed liposomes for drug delivery showcases a method that significantly improves carboplatin encapsulation, highlighting its role in optimizing chemotherapeutic drug formulations (Wehbe et al., 2017).Targeted drug delivery for cardiovascular diseases: DSPE-PEG(2000) Carboxy was integral in the development of PEGylated-nanoliposomal formulations of clusterin, aimed at treating amyloidogenic light chain-induced endothelial dysfunction, underscoring its utility in targeted cardiovascular therapies (Guzman-Villanueva et al., 2018).
- Packaging: 5 mL Amber Glass Screw Cap Vial (880138P-25MG)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: powder
packaging: package of 1 × 10 mg
manufacturer/tradename: Avanti Polar Lipids
application(s): advanced drug delivery
lipid type: polymerizable lipids
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
package of 1 × 10 mg
manufacturer/tradename:
Avanti Polar Lipids
application(s):
advanced drug delivery
lipid type:
polymerizable lipids
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1x25 mg (880144P-25MG)
manufacturer/tradename: Avanti Polar Lipids
application(s): advanced drug delivery
lipid type: polymerizable lipids
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1x25 mg (880144P-25MG)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
advanced drug delivery
lipid type:
polymerizable lipids
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1x25 mg (880145P-25MG)
manufacturer/tradename: Avanti Polar Lipids
application(s): advanced drug delivery
lipid type: polymerizable lipids
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1x25 mg (880145P-25MG)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
advanced drug delivery
lipid type:
polymerizable lipids
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1x25 mg (880146P-25MG)
manufacturer/tradename: Avanti Polar Lipids
application(s): advanced drug delivery
lipid type: polymerizable lipids
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1x25 mg (880146P-25MG)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
advanced drug delivery
lipid type:
polymerizable lipids
shipped in:
dry ice
storage temp.:
−20°C